Jim Cramer on SI-BONE, Inc.: “We’re Not Going to Buy the Money Losers”

Company Overview - SI-BONE, Inc. (NASDAQ:SIBN) specializes in developing and selling medical devices aimed at treating musculoskeletal disorders in the sacropelvic area, including minimally invasive implants for sacroiliac joint dysfunction, pelvic trauma, and spinal support [3]. Stock Performance - The stock has experienced a decline of approximately 30% since January, raising concerns about its financial performance [1]. - Jim Cramer expressed skepticism regarding the stock's potential, indicating that the company is losing too much money and that the current market environment is challenging for money-losing stocks [1]. Investment Sentiment - Cramer acknowledged the speculative nature of SI-BONE, describing it as a "great, great speculation" and indicated a willingness to further investigate the company due to its frequent mention in discussions [3]. - Despite recognizing the potential of SI-BONE as an investment, there is a belief that certain AI stocks present greater upside potential with less downside risk [4].